「Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection」の関連論文
-
The treatment strategy of R0 resection in colorectal cancer with synchronous para-aortic lymph node metastasis
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
-
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Surgical Site Infections and Inflammatory Reaction After Cardiac Surgery; Bedside Artificial Pancreas Versus Conventional Insulin Therapy: A Propensity Score–Matched Analysis
-
Tooth brushing, tooth loss, and risk of upper aerodigestive tract cancer: a cohort study of Japanese dentisits
-
The role of inflammatory biomarkers in predicting primary acquired nasolacrimal duct obstruction and postoperative recurrence
-
Establishment of a radiation-induced vocal fold fibrosis mouse model
-
腎移植後に発生した悪性腫瘍の臨床的検討
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Relationship of Mitochondrial-Related Protein Expression with the Differentiation, Metastasis, and Poor Prognosis of Oral Squamous Cell Carcinoma
-
The Advantages of Robotic Gastrectomy over Laparoscopic Surgery for Gastric Cancer
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
Impact of fractional exhaled nitric oxide on the outcomes of lung resection surgery: a prospective study.
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study
-
Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study
-
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
-
Feasibility of targeting Traf2-and-Nck-Interacting kinase in synovial sarcoma (本文)
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
-
Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis
-
Neutrophil Extracellular Traps Promote Metastases of Colorectal Cancers through Activation of ERK Signaling by Releasing Neutrophil Elastase
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Locoregional recurrence via mucus-mediated extension following lung resection for mucinous tumors.
-
Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound
-
The Essence of Clinical Practice Guidelines for Ossification of Spinal Ligaments, 2019: 7. Treatment of Thoracic OLF
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
The Elevation in Preoperative Procalcitonin Is Associated with a Poor Prognosis for Patients Undergoing Resection for Colorectal Cancer.
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure
-
術後放射線療法を施行し5年間再発を認めなかった後腹膜脱分化型脂肪肉腫の1例
-
Intramuscular Adipose Tissue Content Predicts Patient Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
-
Consumption of coffee and antioxidant vitamins and risk of lung cancer in Japan
-
Prognosis of Patients with Esophageal Carcinoma following Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients based on the Comprehensive Registry of Esophageal Cancer in Japan
-
Supernatant from activated omentum accelerates wound healing in diabetic mice wound model
-
Analysis of uterine corporeal mesenchymal tumors occurring after menopause
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
-
Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population
-
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer
-
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPAEnriched Oral Supplement in Advanced Pancreatic Cancer